Text Size

Beijing Percutaneous Coronary Intervention Registry (BJPCI Registry)

This study is currently recruiting participants.
Verified September 2011 by Cardiovascular Institute & Fuwai Hospital
Sponsor:
Information provided by (Responsible Party):
Yang yuejin, Cardiovascular Institute & Fuwai Hospital
ClinicalTrials.gov Identifier:
NCT01417325
First received: August 15, 2011
Last updated: September 16, 2011
Last verified: September 2011
History of Changes
  Purpose

The registry study is to obtain the state of the art of the percutaneous coronary intervention state treatment for coronary heart disease in Beijing area of P.R.China in a real world. The data are collected from 48 hospitals in Beijing area using an uploading system through internet.


Condition
Coronary Heart Disease

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: A Registry Study of Percutaneous Coronary Intervention Treatment in Beijing Area of P.R. China

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Cardiovascular Institute & Fuwai Hospital:

Estimated Enrollment: 700000
Study Start Date: January 2010
Estimated Study Completion Date: December 2020
Estimated Primary Completion Date: December 2020 (Final data collection date for primary outcome measure)
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

All the patients receiving coronal artery angiography or percutaneous coronary intervention therapy in selected 48 hospitals of Beijing, P.R.China.

Criteria

Inclusion Criteria:

  • Patients from selected 48 hospitals of Beijing, P.R.China
  • Patients receiving coronal artery angiography or percutaneous coronary intervention therapy

Exclusion Criteria:

  • none
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01417325

Contacts
Contact: Yuejin Yang, Doctor 8610-68314466 yangyjfw@yahoo.com.cn
Contact: Lei Song, Doctor 8610-13910968125 drsongfw@gmail.com

Locations
China, Beijing
Beijing cardiovascular intervention quality control and improvement center Recruiting
Beijing, Beijing, China, 100037
Contact: Yuejin Yang, doctor     8610-88398800     yangyjfw@yahoo.com.cn    
Contact: Lei Song, doctor     8610-13910968125     drsongfw@gmail.com    
Sponsors and Collaborators
Cardiovascular Institute & Fuwai Hospital
Investigators
Study Chair: Yuejin Yang, doctor Fuwai Heart Hospital & Cardiovascular Institute
  More Information

No publications provided

Responsible Party: Yang yuejin, Director of coronary heart disease center, vice president of Fuwai hospital, Cardiovascular Institute & Fuwai Hospital
ClinicalTrials.gov Identifier: NCT01417325     History of Changes
Other Study ID Numbers: Bciqcic-fw-01
Study First Received: August 15, 2011
Last Updated: September 16, 2011
Health Authority: China: Food and Drug Administration

Additional relevant MeSH terms:
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Heart Diseases
 Cardiovascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on June 18, 2013